COMMUNIQUÉS West-GlobeNewswire

GBT Announces New Employment Inducement Grants
05/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on February 1, 2019, the compensation committee of GBT’s board of directors granted [...]
Inspire Medical Systems, Inc. Announces Additional Positive Coverage Policies Issued by Five Blue Cross Blue Shield Healthcare Plans
05/02/2019
MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY
05/02/2019
Going Forward, We Will Be Silent Regarding Future Expectations for REMOXY AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today [...]
PCI Biotech: Invitation to fourth quarter and preliminary 2018 result presentation
05/02/2019
Oslo, Norway, 05 February 2019 - PCI Biotech invites to a presentation of the company's fourth quarter and preliminary 2018 report on Wednesday 13 February 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday [...]
BioSig Appoints John Kowalski to Lead Commercialization of PURE EP
05/02/2019
Electrophysiology Industry Veteran to Lead Sales Strategy for the Company’s Novel Cardiac Signal Acquisition and Processing Technology Santa Monica, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( [...]
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
05/02/2019
FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
MediPharm Labs Aligns Leadership and Organizational Structure For Future Prosperity of Company
05/02/2019
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (the “Company” or “MediPharm Labs”) the leader in specialized, research-driven cannabis extraction, is pleased to announce the [...]
Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference
05/02/2019
WESTPORT, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc. , a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase immune cell recognition [...]
Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug
05/02/2019
HOUSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Recent American Society of Breast Surgeons (ASBrS) Guidelines are Favorable to Next Generation Cryoablation Developer, IceCure Medical
05/02/2019
Plans to Increase Presence at Global Interventional Oncology (IO) Medical Conferences CAESAREA, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Following the American Society of Breast Surgeons (ASBrS) Guideline, which were [...]
OpGen Completes Clinical Trials for its Initial FDA 510(k) Submission
05/02/2019
GAITHERSBURG, Md., Feb. 05, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that it has completed the clinical trials needed to support its 510(k) submission for the detection of antimicrobial [...]
Cyclacel Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference
05/02/2019
BERKELEY HEIGHTS, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on February 12
05/02/2019
REHOVOT, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the fourth quarter and [...]
Emerald Health Therapeutics Secures Proprietary Extraction Technology and Extraction Capabilities in Agreement with Indena
05/02/2019
Emerald receives certain exclusive rights to established Phytosome ® technology to enhance absorption and bioavailability of cannabinoid products Leading global extraction researcher and manufacturer to provide license [...]
Microbix Provides Quality Assessment Products Update
05/02/2019
New Customers, More Products, and Expanding Capacity TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on [...]
BioCryst to Present ZENITH-1 Results at American Academy of Allergy, Asthma & Immunology Annual Meeting
05/02/2019
RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present an abstract including results from the ZENITH-1 study at the [...]
Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary
05/02/2019
Investment will enable Melt to fund the development of its patented, non-opioid sublingual sedation and analgesia drug candidate, MELT-100 SAN DIEGO and BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, [...]
Protalix BioTherapeutics Presents Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 15th Annual WORLDSymposium™ 2019
05/02/2019
~ Pharmacokinetic data from patients treated in the study show that infusion of pegunigalsidase alfa every 4 weeks results in the presence of continuous active enzyme throughout the entire infusion interval~ ~Continuous [...]
Revive Announces Closing of the First Tranche of Its Non-Brokered Private Placement for Total Gross Proceeds of Over $1 Million
05/02/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]

Pages